Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin

Stopped early · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Insulin Resistance, Hypermetabolism, Hyperglycemia

In brief

Massive pediatric burns are associated with a persistent and sustained hypermetabolic response characterized by elevated levels of circulating catecholamine's, cortisol, and glucagon's, which can cause extreme muscle wasting, immunodeficiency, and delay in wound healing. Insulin and metformin have demonstrated anabolic activity with minimal associated side effects. However, it is unknown whether the beneficial effects arise from tight euglycemic control or direct effect of insulin action. We hypothesize that during acute hospitalization, administration of metformin at a dose titrated to maintain blood glucose between 80-180 mg/dl will accelerate wound healing and recovery in children with severe thermal injury and will have beneficial long-term effects on muscle strength, immune function, and wound healing.

Key facts

Study ID
NCT01666665
Run by
The University of Texas Medical Branch, Galveston
People needed
36
Starts
2012-11-01
Expected to finish
2019-04-23
Last updated by the study team
2019-11-29

Who can join

Age: 10 and older, up to 19. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.